Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases: An outcome analysis of a pooled multi-platform patient cohort

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma, Robert Olson, Stephen Harrow et al. · The Lancet · 2019 · 1.8K citations

Open-label Trial, Radiation Therapy, Medicine +7

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Daniel R. Gomez, Chad Tang, Jianjun Zhang et al. · Journal of Clinical Oncology · 2019 · 1.2K citations · Full text

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases

Kyle E. Rusthoven, Brian D. Kavanagh, Stuart H. Burri et al. · Journal of Clinical Oncology · 2009 · 1.1K citations · Full text

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases

Kyle E. Rusthoven, Brian D. Kavanagh, Higinia R. Cárdenes et al. · Journal of Clinical Oncology · 2009 · 797 citations

Intrafractional tumor motion: lung and liver

Hiroki Shirato, Yvette Seppenwoolde, Kei Kitamura et al. · Seminars in Radiation Oncology · 2004 · 389 citations

Surgical Oncology, Hepatology, Intrafractional Tumor Motion +6